ATR
Medical Instruments & Supplies · Healthcare
Head of Investor Relations
Head of Investor Relations
Aptargroup, Inc. (ATR)Equibles does not estimate personal net worth.
Get an email with a short summary when Aptargroup, Inc. publishes a filing, an earnings call transcript or a press release.
Get ATR alertsMary Skafidas is recorded as Head of Investor Relations at Aptargroup, Inc. (ATR). Mary Skafidas has spoken on 14 earnings calls and 2 other investor events across 1 company, most recently for Aptargroup, Inc. on September 9, 2026. Aptargroup, Inc. is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Aptargroup, Inc. includes Gael Touya (CEO and Board Member), Daniel Ackerman (Chief Accounting Officer), B. Craig Owens (Board Member) and 7 others.
“If I could add because this is really a capability that Gael started the services part so this ability to reformulate an injectable into something that's measly delivered, respiratory delivered.”
“Joining me on today's call are Stefan Tanda, our president and CEO, Vanessa Kanu, executive vice president and CFO, and Gael Tuya, our CEO designate and president of Aptar Pharma.”
“Joining me on today's call are Stefan Tanda, our President and CEO, Vanessa Canu, Executive Vice President and CFO, and Gael Tuya, our CEO designate and President of Aptar Pharma.”
“If I could add before, when you look at it, Profan mentioned that we had made available in the pipeline forward-looking for pharma for prescription, and not just prescription division, prescription, including injectables.”
“Our speakers for the call are Stefan Tanda, our President and CEO, and Vanessa Kanu, our Executive Vice President and CFO. Our press release and accompanying slide deck have been posted on our website under the Investor Relations page.”
ATR
Medical Instruments & Supplies · Healthcare
Head of Investor Relations